Cannabinoid and Xanthine Compositions for Nootropic Effects
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current medicinal compositions of cannabinoids lack bioavailability, rapid action, and consistent effects, and do not provide a nootropic effect or adequately reduce anxiety when used alone.
Innovation Solution
Combining cannabinoids like THC, CBD, or CBN with xanthines such as caffeine, along with optional yohimbine derivatives, to create bioavailable, fast-acting medicinal compositions that offer enhanced cognitive benefits and reduced anxiety.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If cannabinoids are used alone, then they provide medicinal benefits, but they lack bioavailability and rapid action
Solution Approach 1:
The patent combines cannabinoids with xanthines (such as caffeine) and optionally yohimbine derivatives to create a composite composition. This merging of different pharmacologically active substances produces synergistic effects that enhance both bioavailability and speed of action, resolving the contradiction between reliable delivery and rapid effect.
Solution Approach 2:
The invention creates a composite medicinal composition integrating multiple active ingredients (cannabinoids, xanthines, and yohimbine derivatives) with specific dosing ratios. This composite approach leverages the complementary pharmacological properties of each component to achieve improved bioavailability and faster onset while maintaining medicinal benefits.
2Adaptability or versatility
If cannabinoids are used alone, then they provide medicinal benefits, but they do not provide a nootropic effect
Solution Approach 1:
The composite composition performs multiple functions simultaneously: it provides the medicinal benefits of cannabinoids, adds the nootropic effects of xanthines (improving cognition, focus, and energy), and includes yohimbine derivatives for enhanced anxiety reduction. This multi-functionality resolves the contradiction by expanding the therapeutic scope without compromising the core medicinal effects.
3Object-affected harmful factors
If yohimbine is ingested, then anxiety is reduced, but side effects occur
Solution Approach 1:
The patent specifies precise dosing parameters for yohimbine derivatives (0.1-10 mg per serving) within the composite composition. By controlling the concentration and dosage of yohimbine alongside cannabinoids and xanthines, the formulation optimizes anxiety reduction while minimizing side effects through parameter optimization rather than using yohimbine alone at higher doses.
Data Source
AI summary
This invention discloses a medicinal composition of matter that effectively provide a nootropic effect beyond the effects simple obtain by cannabinoids alone. And, effectively reduce anxiety due to ingestion of xanthines containing oral products.